Long-term safety and efficacy of prolonged-release fampridine in Japanese patients with multiple sclerosis (MS): Results from the motion-Japan Part b study

Authors
Category Primary study
JournalJournal of the Neurological Sciences
Year 2017
This article has no abstract
Epistemonikos ID: 321e93c8b41aaf3e53044f900a2b48f2744cc145
First added on: Feb 08, 2025